Cipla Therapeutics partners with SIGA Technologies for antibacterial drugs

By on    Pharma Industry News  

Cipla Therapeutics partners with SIGA Technologies for antibacterial drugs

Cipla Therapeutics, an Indian pharma company, and SIGA Technologies have entered into a partnership to provide sustained innovation and access to novel antibacterial drugs, especially against biothreats. SIGA Technologies is a US-based commercial-stage pharmaceutical company, whose lead product is TPOXX. Also called tecovirimat and ST-246, TPOXX is an orally administered and intravenous (IV) formulation antiviral […]

Siga Technologies secures Tecovirimat FDA approval for smallpox treatment

By on    Pharma Industry News  

Siga Technologies secures Tecovirimat FDA approval for smallpox treatment

Siga Technologies has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of its orally administered antiviral drug, TPOXX (tecovirimat), for the treatment of smallpox. This approval marks a critical development in public health preparedness and bioterrorism defense. Developed in collaboration with the U.S. Department of Health and Human Services’ Biomedical […]